Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 61 | 120 | 1,145 | 4,907 | 2,067 |
| Gross Profit | 61 | 120 | 1,145 | 4,907 | 2,067 |
| Operating Expenses | 164,673 | 93,350 | 39,442 | 25,793 | 24,919 |
| Operating Income | -164,612 | -93,230 | -38,297 | -20,886 | -22,852 |
| Other Income | 499 | 755 | 349 | 37 | 87 |
| Pre-tax Income | -164,113 | -92,475 | -37,948 | -20,849 | -22,765 |
| Income Tax | 330 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -164,443 | -92,475 | -37,948 | -20,849 | -22,765 |
| Net Income | $-164,443 | $-92,475 | $-37,948 | $-20,849 | $-22,765 |
| EPS Basic Total Ops | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 |
| EPS Basic Continuous Ops | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 |
| EPS Diluted Total Ops | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 |
| EPS Diluted Continuous Ops | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 |
| EBITDA(a) | $-166,025 | $-92,540 | $-36,690 | $-20,910 | $-22,462 |